On August 16-19, 2019, Shanghai Medicilon Inc. successfully organized The 5th Advanced Training Course for Non-clinical Safety Evaluation of Drugs for Study Director, which hosted by Drug Safety Evaluation Research Committee of China Pharmaceutical Association and National Institutes for Food and Drug Control. The training course lasted for 2 days and 13 experts were invitedRead more
Press Events
By medicilon | Our Events | 4 August, 2019 |
On August 2, 2019, “The Medicilon 15th Anniversary Series Tour Forum – Preclinical Research Seminar” was held at the Pudong International Talent Hub. There were 150 pharmaceutical R&D experts from nearly 100 pharmaceutical companies to attend the seminar. The seminar was hosted by Shanghai Medicilon Inc. and co-organized by Pudong International Talent Hub and ShanghaiRead more
By medicilon | Our Events | 12 July, 2019 |
The 15th International Congress of Toxicology (ICTXV 2019) will take place in Hawaii, HI from July 15-18. The ICTXV is a forum for scientists in academia, government, and industry from around the world to learn about the latest developments in toxicological science and regulation. Our VP of DMPK, Dr. Baomin Xin, will attend the conferenceRead more
By medicilon | Press Events | 7 June, 2019 |
Recently, ImmuneOnco Biopharma, a partner of Shanghai Medicilon Inc., announced that its newly developed immune checkpoint inhibitor has been approved by the National Medical Products Administration (NMPA), which marks the beginning of a new phase of research on the first CD47 fusion protein drug in China. It is reported that ImmuneOnco Biopharma submitted the INDRead more
By medicilon | Uncategorized | 4 June, 2019 |
The 2019 BIO International Conference (BIO) will take place in Philadelphia, PA from June 3-6. The BIO attracts 16,000 biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. Our Directors of BD, Dr. Walter Xie, Dr. Mingzhu Zhang and Sally Tang will attend theRead more
